E-viri
Recenzirano
-
Gregorc, V; Hidalgo, M; Spreafico, A; Cusatis, G; Ludovini, V; Ingersoll, RG; Marsh, S; Steinberg, SM; Viganò, MG; Ghio, D; Villa, E; Sparreboom, A; Baker, SD
Clinical pharmacology and therapeutics, March 2008, Letnik: 83, Številka: 3Journal Article
The purpose of this study was to evaluate associations between germline epidermal growth factor receptor (EGFR) variants involved in transcriptional regulation and overall survival in white patients with non‐small‐cell lung cancer (NSCLC) treated with the EGFR tyrosine kinase inhibitor, gefitinib. Of 175 consecutive patients treated with oral gefitinib (250 mg/day), 170 (median age: 67 years; 72% men) were evaluable for genotyping and survival. Fifty‐five patients (33%) had stable disease and 17 (10%) had an objective response. The most common of four haplotypes was G‐C (EGFR*1) at the EGFR −216G>T and −191C>A loci (frequency, 0.45). After adjusting for performance status, previous platinum‐containing chemotherapy and occurrence of skin rash or diarrhea during the first treatment cycle in patients with performance status 0 or 1 (N=139), the absence of EGFR*1 was associated with significantly better survival (hazard ratio: 0.54; 95% confidence interval: 0.32–0.91; P=0.015). The results may help identify patients with NSCLC who can benefit from gefitinib treatment. Clinical Pharmacology & Therapeutics (2008) 83, 3, 477–484.doi:10.1038/sj.clpt.6100320
Avtor
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.